May 2, 2013
/PRNewswire-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in
, today announced that the Company plans to release first quarter 2013 financial results on
Wednesday, May 8, 2013
after the market closes.
The Company's management will hold a conference call at
7:30 a.m. ET
Thursday, May 9, 2013
to discuss first quarter 2013 results. Listeners may access the call by dialing 1-480-629-9857. A live and archived webcast of the conference call will be available at
, with event ID: 104670. A replay of the call will be available through
May 23, 2013
by dialing 1-858-384-5517, access code: 4618459.
About China Biologic Products, Inc.
China Biologic Products, Inc. (Nasdaq: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in
. The Company's products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in
and manufactures over 20 plasma-based products through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. The Company also has an equity investment in Xi'an Huitian Blood Products Co., Ltd. The Company sells its products to hospitals and other healthcare facilities in
. For additional information, please see the Company's website
China Biologic Products, Inc.Mr.
Vice President Phone: +86-10-6598-3099Email:
Phone: +86-10-6583-7511 or +1-646-405-5191E-mail:
SOURCE China Biologic Products, Inc.